Bank Mandiri (Persero) Tbk PT
IDX:BMRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bank Mandiri (Persero) Tbk PT
IDX:BMRI
|
ID |
|
Ally Financial Inc
NYSE:ALLY
|
US |
|
Helvetia Holding AG
SIX:HELN
|
CH |
|
B
|
Bank Negara Indonesia (Persero) Tbk PT
XMUN:BKE1
|
ID |
|
T
|
Telefonaktiebolaget LM Ericsson
OTC:ERIXF
|
SE |
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
Wall St Price Targets
BMRI Price Targets Summary
Bank Mandiri (Persero) Tbk PT
According to Wall Street analysts, the average 1-year price target for BMRI is 5 641.08 IDR with a low forecast of 3 628.93 IDR and a high forecast of 7 140 IDR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMRI's stock price target?
Price Target
5 641.08
IDR
According to Wall Street analysts, the average 1-year price target for BMRI is 5 641.08 IDR with a low forecast of 3 628.93 IDR and a high forecast of 7 140 IDR.
What is the Revenue forecast for Bank Mandiri (Persero) Tbk PT?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Bank Mandiri (Persero) Tbk PT?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 6%.
